Total Payments
$176,297
2024 Payments
$3,046
Companies
37
Transactions
757
Medicare Patients
409
Medicare Billing
$37,935
Payment Breakdown by Category
Consulting$125,952 (71.4%)
Research$18,165 (10.3%)
Food & Beverage$17,272 (9.8%)
Travel$14,470 (8.2%)
Other$350.00 (0.2%)
Education$87.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $125,952 | 23 | 71.4% |
| Unspecified | $18,165 | 3 | 10.3% |
| Food and Beverage | $17,272 | 713 | 9.8% |
| Travel and Lodging | $14,470 | 15 | 8.2% |
| Honoraria | $350.00 | 1 | 0.2% |
| Education | $87.00 | 2 | 0.0% |
Payments by Type
General
$158,131
754 transactions
Research
$18,165
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MERZ NORTH AMERICA, INC. | $151,422 | 97 | $0 (2024) |
| Allergan, Inc. | $12,202 | 39 | $0 (2022) |
| ABBVIE INC. | $2,557 | 90 | $0 (2024) |
| Galderma Laboratories, L.P. | $2,457 | 99 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,068 | 90 | $0 (2024) |
| LEO Pharma Inc. | $698.30 | 41 | $0 (2024) |
| PFIZER INC. | $599.39 | 32 | $0 (2024) |
| Biofrontera Inc. | $575.76 | 5 | $0 (2023) |
| Incyte Corporation | $558.02 | 40 | $0 (2024) |
| Almirall LLC | $542.60 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,046 | 67 | MERZ NORTH AMERICA, INC. ($1,348) |
| 2023 | $4,235 | 101 | Merz North America, Inc. ($2,307) |
| 2022 | $35,772 | 99 | Merz North America, Inc. ($23,179) |
| 2021 | $7,471 | 98 | MERZ NORTH AMERICA, INC. ($6,096) |
| 2020 | $16,426 | 108 | MERZ NORTH AMERICA, INC. ($15,009) |
| 2019 | $27,474 | 148 | Merz North America, Inc. ($24,852) |
| 2018 | $80,557 | 83 | Merz North America, Inc. ($78,632) |
| 2017 | $1,316 | 53 | Galderma Laboratories, L.P. ($533.46) |
All Payment Transactions
757 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | MERZ NORTH AMERICA, INC. | Xeomin | Travel and Lodging | In-kind items and services | $646.99 | General |
| 11/22/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $1.23 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.16 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: Immunology | ||||||
| 11/12/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation & Immunology | ||||||
| 11/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.36 | General |
| Category: Dermatology | ||||||
| 10/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Dermatology | ||||||
| 09/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: ACNE | ||||||
| 09/19/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $188.33 | General |
| 09/19/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 09/18/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 09/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.30 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Evaluation of the Octave Platform for the Ulthera System for Improving Laxity and Wrinkles on the Decollete | MERZ NORTH AMERICA, INC. | $18,165 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 131 | 159 | $58,576 | $11,196 |
| 2022 | 5 | 112 | 148 | $55,684 | $10,367 |
| 2021 | 5 | 101 | 136 | $53,235 | $9,681 |
| 2020 | 5 | 65 | 80 | $29,182 | $6,691 |
Total Patients
409
Total Services
523
Medicare Billing
$37,935
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 46 | $18,400 | $3,289 | 17.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 35 | $10,528 | $3,169 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $12,600 | $1,799 | 14.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 26 | $7,800 | $1,239 | 15.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 19 | 21 | $7,350 | $1,090 | 14.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 13 | $1,898 | $610.37 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 55 | $22,000 | $3,959 | 18.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 27 | 31 | $9,734 | $2,702 | 27.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 32 | $9,600 | $1,641 | 17.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $7,700 | $1,161 | 15.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 13 | 19 | $6,650 | $904.16 | 13.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 48 | $19,200 | $3,734 | 19.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 23 | 29 | $9,135 | $2,515 | 27.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $11,200 | $1,383 | 12.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 27 | $8,100 | $1,379 | 17.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 12 | 16 | $5,600 | $670.05 | 12.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,300 | $1,690 | 51.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 14 | 16 | $4,832 | $1,445 | 29.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 22 | $8,800 | $1,400 | 15.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 14 | $6,300 | $1,378 | 21.9% |
| 17000 | Destruction of skin growth | Office | 2020 | 13 | 17 | $5,950 | $778.55 | 13.1% |
About Dr. Amanda Doyle, M.D
Dr. Amanda Doyle, M.D is a Dermatology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2011. The National Provider Identifier (NPI) number assigned to this provider is 1497049548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amanda Doyle, M.D has received a total of $176,297 in payments from pharmaceutical and medical device companies, with $3,046 received in 2024. These payments were reported across 757 transactions from 37 companies. The most common payment nature is "Consulting Fee" ($125,952).
As a Medicare-enrolled provider, Doyle has provided services to 409 Medicare beneficiaries, totaling 523 services with total Medicare billing of $37,935. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Brooklyn, NY
- Active Since 06/07/2011
- Last Updated 05/29/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1497049548
Products in Payments
- BOTOX (Biological) $11,525
- Xeomin (Biological) $1,153
- XEOMIN (Biological) $970.31
- SOOLANTRA (Drug) $866.69
- DUPIXENT (Biological) $773.27
- SKYRIZI (Biological) $723.74
- Humira (Biological) $623.35
- EPIDUO FORTE (Drug) $613.69
- OPZELURA (Drug) $558.02
- ENSTILAR (Drug) $470.74
- JUBLIA (Drug) $433.76
- AMELUZ (Drug) $422.93
- Otezla (Drug) $392.00
- ORACEA (Drug) $387.68
- Seysara (Drug) $324.85
- EUCRISA (Drug) $321.50
- AMZEEQ (Drug) $305.89
- CIBINQO (Drug) $277.89
- DORYX (Drug) $221.41
- RINVOQ (Biological) $217.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Brooklyn
Dr. Hilary Baldwin, M.d, M.D
Dermatology — Payments: $1.6M
Dermatology $1.6M
Dr. Steven Baranowitz, Md, MD
Dermatology — Payments: $1.3M
Dermatology $1.3M
Dr. Susan Bard, M.d, M.D
Dermatology — Payments: $291,896
Dermatology $291,896
Dr. Michael Jackson, M.d, M.D
Dermatology — Payments: $153,050
Dermatology $153,050
Sourab Choudhury, Do, DO
Dermatology — Payments: $45,155
Dermatology $45,155
Dr. Tatiana Khrom, M.d, M.D
Dermatology — Payments: $45,019
Dermatology $45,019